Initiating Insulin Therapy in a Patient with Leg Ulcer, Uncontrolled Diabetes, and Cellulitis
In this acute setting with cellulitis and metabolic instability, start basal insulin immediately at 10 units or 0.1-0.2 units/kg once daily, continue metformin if the patient is on it, and medically stabilize the patient with fluid, electrolytes, and insulin while treating the infection. 1
Immediate Management Priorities
Medical Stabilization
- Hospitalization is required because this patient meets criteria for admission: metabolic instability (uncontrolled diabetes), presence of infection (cellulitis), and inability to adequately care for self with an active leg ulcer 1
- Medically stabilize the patient first by correcting fluid status, electrolyte abnormalities, and initiating insulin therapy 1
- The presence of cellulitis with uncontrolled diabetes creates a high-risk situation where infection control and glycemic management must occur simultaneously 2
Infection Management Alongside Insulin Initiation
- Obtain wound cultures from the debrided ulcer base (not swabs of drainage) and blood cultures given the systemic infection 1
- Initiate empirical parenteral antimicrobial therapy immediately while awaiting culture results 1
- Debride the wound appropriately and assess for depth of infection, tissue involvement, and presence of critical limb ischemia 1
Insulin Initiation Strategy
Starting Basal Insulin
Begin with basal insulin at 10 units subcutaneously once daily, or calculate 0.1-0.2 units/kg based on body weight, with the higher end of dosing appropriate given the acute infection and stress hyperglycemia. 1
- Use insulin glargine (100 units/mL) as the preferred basal insulin, either originator or biosimilar, as it provides flat, peakless action over approximately 24 hours 3, 4
- Inject subcutaneously in the upper arms, thighs, or abdomen, rotating sites to prevent lipodystrophy 3
- Administer at the same time each day for consistency 3
Dose Titration Protocol
- Equip the patient with a self-titration algorithm: increase basal insulin by 2 units every 3-7 days until fasting glucose reaches 90-150 mg/dL (5.0-8.3 mmol/L) 5, 6
- Monitor fasting blood glucose daily to guide dose adjustments 1
- In the hospital setting with active infection, more frequent adjustments may be needed as insulin requirements can be higher due to stress and inflammation 2
Continuation of Other Medications
- Continue metformin if the patient is already taking it, as basal insulin is typically prescribed in conjunction with metformin and possibly one additional non-insulin agent 1
- Avoid sulfonylureas during acute illness due to hypoglycemia risk 1
When to Advance Beyond Basal Insulin
Adding Mealtime Insulin
- If basal insulin has been titrated to acceptable fasting glucose levels but HbA1c or postprandial glucose remains above target, consider adding mealtime insulin 1
- Use rapid-acting insulin analogues (lispro, aspart, or glulisine) administered immediately before meals 1, 4
- Start with one injection before the largest meal, then expand to three meals as needed 1
Severe Hyperglycemia Considerations
- If blood glucose is 300-350 mg/dL (16.7-19.4 mmol/L) or higher and/or HbA1c is 10-12%, especially with catabolic features, consider starting basal plus mealtime insulin immediately rather than basal alone. 1
- Given the acute infection and leg ulcer, this patient likely has significant stress hyperglycemia warranting more aggressive initial therapy 2
Critical Safety Considerations
Hypoglycemia Prevention
- Monitor blood glucose 2-4 hours post-injection when insulin action peaks, particularly important in patients with impaired renal function or those on other glucose-lowering medications 5
- Avoid administering basal insulin at bedtime initially; once-daily dosing can be at any consistent time but morning administration may reduce nocturnal hypoglycemia risk during titration 5
- Educate the patient on recognition and treatment of hypoglycemia 1
Injection Technique and Site Care
- Do not inject insulin where the skin has ulcers, is infected, tender, bruised, or damaged 3
- Given the leg ulcer, avoid the affected leg entirely for insulin injections 3
- Use proper sterile technique with new needles for each injection to prevent infection 3
Wound-Specific Considerations
Offloading the Ulcer
- While initiating insulin therapy, simultaneously implement appropriate offloading strategies for the leg ulcer 1
- For neuropathic plantar ulcers without ischemia or uncontrolled infection, use non-removable knee-high devices with appropriate foot-device interface (strong recommendation, high-quality evidence) 1
- Instruct the patient not to walk barefoot, in socks only, or in thin-soled slippers 1
Glycemic Control for Wound Healing
- Achieving better glycemic control is essential for wound healing, as hyperglycemia impairs immune function and tissue repair 2, 7
- Target premeal glucose of 90-150 mg/dL for most patients to optimize healing while minimizing hypoglycemia risk 5
Common Pitfalls to Avoid
- Do not delay insulin initiation in patients not achieving glycemic goals, especially in the setting of acute infection 1
- Do not use sliding scale insulin (SSI) alone as the primary strategy; it results in worse glycemic control compared to basal-bolus regimens and should only be used temporarily for correction doses if needed 7
- Do not remove insulin from the pen with a syringe, as this can result in incorrect dosing 3
- Avoid using the same needle twice, as this increases infection risk and can cause needle blockage 3
Monitoring and Follow-Up
- Re-evaluate the patient at least daily while hospitalized for infection response and glycemic control 1
- Adjust antimicrobial therapy based on culture results and clinical response 1
- Once discharged, arrange follow-up in 1-2 weeks to reassess wound healing, glycemic control, and insulin dose adequacy 1
- Continue dose titration persistently until fasting glucose targets are achieved, which may take months 6